Epidemiologic and morphologic features of canine senile plaques (SPs) and cerebral amyloid angiopathy (CAA) were examined in 69 necropsied dogs. Dogs having only SPs (diffuse plaques) frequently suffered from malignant neoplasms, and their mean age was significantly lower than that of dogs with CAA only. Morphologically, diffuse plaques showed wide distribution compared with amyloid plaques or CAA and were predominantly concentrated in the frontal cortex. We were unable to find any significant relationship between the seventy of the SPs and individual age. These findings may indicate that the occurrence of canine SPs is not strictly associated with aging only and that additional factors are related to the occurrence of SPs, especially diffuse plaques.
Beta-amyloidosis, defined as the presence of senile plaques (SPs) and cerebral amyloid angiopathy (CAA), has been reported in the brains of aged non-human primates, bears, and dogs.6 These species may therefore serve as animal models for investigating beta-amyloidosis in Alzheimer's disease. l o Although the morphologic and immunohistochemical features of SPs and CAA have been reported in aged dogs,* there is little information concerning epidemiologic features, such as breed or sex predisposition, and related disorders.2 In addition, the distribution patterns of canine SPs and CAA and regional differences in lesion occurrence or seventy have not been presented. The purpose of this retrospective study was to investigate the epidemiologic and morphologic features of SPs and CAA in a group of dogs.
Necropsied dogs (N = 69), aged 7 to 20 years, that had been observed to have CAA and/or SPs by previous histologic examinations were used in the present study. The clin-ical and pathologic histories, such as individual age, sex, breed, and major pathological diagnoses, were investigated from previous records in our laboratories to determine the epidemiologic features of these brain lesions. Paraffin sections of the cerebral cortex and hippocampus of these 69 dogs were made and stained with hematoxylin and eosin (HE) periodic acid-methenamine silver (PAM) and alkaline Congo red to reconfirm CAA and SPs. Immunostaining was also performed by the avidin-biotin peroxidase complex (ABC) method using a system kit (Vectastain PK400, Vector Laboratories, Burlingame, CA). A primary rabbit antibody against a synthetic peptide corresponding to amino acids 1-40 of beta protein (Boehringer Mannheim, Mannheim, Germany) and a mouse monoclonal antibody against neurofilament (NF; Dako, Carpinteria, CA) were used. Biotinylated goat antirabbit and anti-mouse immunoglobulins (Dako) were employed as the secondary antibody. Visualization was done classic plaque (c). Periodic acid-methenamine silver stain. methenamine silver. Bar = 40 pm. using 3,3'-diaminobenzidine (Sigma, St. Louis, MO). To enhance the immunoreactivity for beta protein, deparaffinized sections were incubated in 90% formic acid at room temperature for 10 minutes.
According to the brain lesions present, the 69 dogs were classified into three groups: group A, those with only SPs, 13 cases (mean age, 10.5 Ifr 2.5 years); group B, those with only CAA, 23 cases (mean age, 13.9 f 2.2 years); and group C, those having both CAA and SPs, 33 cases (mean age, 14.7 k 2.6 years). To evaluate the difference of individual age in each group, the data were analyzed by the x2 test. To clarify the distribution of SPs or CAA, 33 dogs (group A, 6 cases; group B, 7 cases; group C, 20 cases) were selected (almost all brain regions from these dogs had been stored and could be investigated histopathologically). Paraffin sections of the olfactory bulb; frontal, temporal, parietal, and occipital cortex; caudate nucleus; thalamus; hippocampus; cerebellum; medulla; pons; and spinal cord were made and stained with PAM and alkaline Congo red. For the evaluation of the density of SPs among 46 cases (groups A, C), 26 dogs with cerebral cortex available for investigation were selected. Paraffin sections from the same part of the frontal, parietal, temporal, and occipital cortex of these 26 dogs were stained with PAM and viewed with a video camera system (Sony/ model DXC-M3, Sony, Japan) with a 10 x objective at 175 x magnification (the field was 1.35 sq. mm). The density of Bar = 61 hm. Fig. l d . Perivascufar plaque. Periodic acid-SPs was calculated as the average number of SPs per square millimeter in seven randomly selected regions. Data were analyzed statistically by the t-test.
Histopathologically, CAA was characterized by amyloid deposits around capillaries and in the tunica media of arterioles by alkaline Congo red and beta-immunostaining. According to morphologic characteristics, SPs were classified as difise or amyloid plaques. Diffuse plaques appeared with PAM staining as diffuse accumulations of PAM-positive fibrous material but did not appear with HE or alkaline Congo red staining ( Fig. la) . Amyloid plaques appeared as amyloid deposits in the neuropil and contained three morphologic subtypes: 1) those mimicking human primitive plaques with hyalinous argyrophilic granules and slight amyloid deposits ( Fig. lb) , 2) those similar to classic human plaques with a well-defined amyloid core and a halo of argyrophilic swollen neurites (Fig. lc) , and 3) perivascular plaques thought to be formed by the invasion of vascular amyloid into the neuropil (Fig. Id) . The sections stained with PAM stain revealed almost all the morphologic characteristics of these amyloid plaques. Alkaline Congo red stain sometimes failed to detect a subset of plaques consisting of very slight amyloid deposits. Immunohistochemically, both CAA and SPs showed intense reaction to beta protein, although formic-acid pretreatment was required for diffuse plaque staining. For the detection of both CAA and SPs, immunostaining was superior to alkaline Congo red or PAM staining, although it was sometimes difficult to distinguish amyloid plaque subtypes by beta-immunostaining due to intense immunoreactivity.
The average individual age in each group (A to C) is shown in Fig. 2 . The occurrence of CAA tended to be higher in older individuals compared with SPs ( Fig. 2) . A significant difference was noted between groups A and B (P < 0.05) and between groups A and C (P < 0.01). In group A, 11 of 13 dogs had malignant tumors, including mammary gland adenocarcinoma (three cases), lymphosarcoma (three cases), cholangiocellular carcinoma, squamous cell carcinoma, osteosarcoma, bronchogenic carcinoma, and seminoma (one case each). The other two had Cushing's syndrome or liver cirrhosis. The individual sex and breed varied in each group. Both diffuse and amyloid plaques were observed in group C, but two (dog Nos. 17, 65) had only amyloid plaques without diffuse plaques. In contrast, amyloid plaques were not detected in group A.
The distribution pattern of SPs and CAA is shown in Table  1 . Amyloid deposition in the arterioles was found frequently in the cerebral meninges or cortex and cerebellar meninges, but that in capillaries was restricted mainly to the cerebral cortex. Diffuse plaques were distributed not only in the cerebral cortex but also in the hippocampus and the head of the caudate nucleus. Among these sites, the frontal cortex showed the highest occurrence. The morphologic features of diffuse plaques in the hippocampus were quite different from those in other regions, appearing in the molecular layer with a ribbon or smearlike morphology (Fig. 3) . Amyloid plaques were distributed mainly in the cerebral cortex, predominantly in the frontal cortex. In the head of the caudate nu- t Dogs were selected from group B (7) and grolip C (20). Among 26 cases examined for SP density determination, 22 had significant numbers. In almost all cases, SPs, es-pecially diffuse plaques, were detected in the frontal cortex with high density (Table 2) . By statistical analysis, a significant difference was found between the density of SPs in the frontal cortex and those in the parietal cortex (P < 0.05). We were unable to find any significant relationship between individual age and SP seventy. For example, one 13-year-old dog (dog No. 23) had more SPs than other older dogs. Moreover, the density of SPs in 7-and 9-year-old dogs (dog Nos. 2, 5) was relatively higher than that in the oldest three dogs, which were 18 and 20 years old (dog Nos. 62, 68, 69 ). In addition, among four Yorkshire temers (dog Nos. 5, 16, 56, 68), the youngest (dog No. 5) had the most SPs.
In this study, the occurrence of CAA was concentrated predominantly in older dogs, suggesting that the occurrence of canine CAA might increase with age, as described previously by Dahme and Schroeder.2 In contrast, diffuse plaques appeared even in 7-or 9-year-old dogs with a high density and wide distribution. Moreover, the severity of the plaques was thought to be unrelated to individual age. These observations may represent individual differences in the incidence of canine diffuse plaques (initial deposition of beta protein). 02  7  05  9  12  12  15  12  16  12  17  12  18  12  19  12  22  13  23  13  25  13  39  14  40  14  52  15  53  15  55  16  56  16  59  16  60  17  62  18  68  20  69 20 * Average number of senile plaques per square millimeter in seven regions. The number in parentheses is the number of amyloid plaques per square millimeter in seven regions. The dogs examined were selected from groups A (3) and C (1 9). Vet Pathol 33:2, 1996 associated with aging. These findings suggest that additional factors other than aging and breed may influence the development of lesions in dogs. In the present study, dogs with only diffuse plaques frequently suffered from malignant metastatic tumors. The significance of this observation is currently unknown. Cummings et al.' suggested that some risk factors, such as health and environment, might play a role in the formation of canine SPs. Moreover, several heat shock proteins (HSPs), such as HSP 70 and ubiquitin, induced by various stresses, are suggested to be related to the pathogenesis of Alzheimer's disease.) When considered with our present data, this suggests that prolonged systemic stress induced by several conditions, such as malignant tumors, may be related to beta-amyloidosis in dogs just like other types of amyloidosis (ix., systemic AA-amyloidosis).
Odomori et al.4 demonstrated the distribution of beta-protein in the brains of both nondemented elderly individuals (50 to 98 years old) and patients with Alzheimer's disease. As cbmpared with previous results in human cases,4 canine CAPi was considered to appear more frequently with a wide distribution than it does in nondemented elderly individuals. Such severity of CAA might be a specific characteristic of the aged dog. On the other hand, canine SPs were seen most frequently in the frontal cortex with high density. In the hippocampus, diffuse plaques or parenchymal beta protein deposits were formed in the molecular layer, with a ribbon or smearlike morphology, as reported previously.l,1° Moreover, amyloid pattern of SPs in both nondemented elderly individuals and dogs was almost equal, while plaques in the head of the caudate nucleus had well-defined, swollen neurites compared with those in the cerebral cortex. Previously, the morphology of SPs had been thought to change according to their maturation, from diffuse plaque to primitive, classic, and burnout plaques.9 However, Ogomori et al.4 suggested that the morphologic features of SPs might be determined by the distinct anatomical location of the brain regions where they formed. A similar interpretation can be applied to explain the morphologic differences in canine SPs observed among different brain regions.
In this study, both amyloid and diffuse plaques were detected only in group C, the oldest age group with both SPs and CAA, and two dogs of this group had only amyloid plaques. In contrast, the dogs of group A did not show amyloid plaques. We offer two hypotheses for the interpretation of these phenomena: 1) If amyloid plaques are formed by the maturation of diffuse plaques, it may take a long time for plaque formation, so amyloid plaques would appear predominantly in aged dogs. However, this does not explain why amyloid plaques sometimes appear without diffuse plaques. 2) Since canine amyloid plaques may be formed as a result of amyloid degeneration of capillaries, the plaques appdared only in the dogs of group C, which had also CAA, and hot in those of group A. Uchida et al.' examined canine amyloid plaques using double-labeling immunohistochem-istry and showed the close relationship between the plaques and CAA ofthe capillaries. These results strengthen this latter hypothesis.
In conclusion, this study demonstrated epidemiologic and morphologic features of CAA and SPs in canine brains, providing data for future investigation of dogs as an animal model of beta-amyloidosis.
